Cargando…

Physiologically Relevant Oxygen Concentration (6% O(2)) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro

Cancer cell phenotype largely depends on oxygen availability. The atmospheric oxygen concentration (21%) used in in vitro studies is much higher than in any human tissue. Using well-characterized patient-derived melanoma cell lines, we compared: (i) activities of several signaling pathways, and (ii)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osrodek, Marta, Hartman, Mariusz L., Czyz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747123/ https://www.ncbi.nlm.nih.gov/pubmed/31461993 http://dx.doi.org/10.3390/ijms20174203

Ejemplares similares

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
por: Czyz, Malgorzata, et al.
Publicado: (2019)

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of (V600E)BRAF melanoma cells and their response to vemurafenib and trametinib in vitro
por: Zalesna, Izabela, et al.
Publicado: (2017)

17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different genetic subtypes
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

MITF in melanoma: mechanisms behind its expression and activity
por: Hartman, Mariusz L., et al.
Publicado: (2014)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

MCL-1, BCL-X(L) and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
por: Hartman, Mariusz L., et al.
Publicado: (2015)

Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype
por: Hartman, Mariusz L., et al.
Publicado: (2014)

Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal
por: Hartman, Mariusz L., et al.
Publicado: (2023)

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
por: Hartman, Mariusz L., et al.
Publicado: (2020)

Trametinib-Resistant Melanoma Cells Displaying MITF(high)/NGFR(low)/IL-8(low) Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge
por: Koziej, Paulina, et al.
Publicado: (2023)

Targeting Genome Stability in Melanoma—A New Approach to an Old Field
por: Osrodek, Marta, et al.
Publicado: (2021)

TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF(V600E) melanoma cells
por: Hartman, Mariusz L., et al.
Publicado: (2019)

Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2014)

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations
por: Hartman, Mariusz L., et al.
Publicado: (2016)

WNT Signaling in Melanoma
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2020)

17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
por: Hartman, Mariusz L., et al.
Publicado: (2020)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

The Interplay between Tumour Microenvironment Components in Malignant Melanoma
por: Amalinei, Cornelia, et al.
Publicado: (2022)

Role of miRNAs in Melanoma Metastasis
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2019)

The Functional Role of Long Non-Coding RNAs in Melanoma
por: Wozniak, Michal, et al.
Publicado: (2021)

The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
por: Barbai, Tamás, et al.
Publicado: (2015)

Deciphering the Functional Role of RIPK4 in Melanoma
por: Madej, Ewelina, et al.
Publicado: (2021)

Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2023)

Spontaneously occurring melanoma in animals and their relevance to human melanoma
por: van der Weyden, Louise, et al.
Publicado: (2020)

Non-Apoptotic Cell Death Signaling Pathways in Melanoma
por: Hartman, Mariusz L.
Publicado: (2020)

Is oestrogen an important player in melanoma progression?
por: Janik, Marcelina E., et al.
Publicado: (2014)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy
por: Kluszczynska, Katarzyna, et al.
Publicado: (2023)

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing
por: Miskolczi, Zsofia, et al.
Publicado: (2018)

The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2020)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Melanoma: tumor microenvironment and new treatments
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2017)

The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells – a case of inter‐tumor heterogeneity
por: Izraely, Sivan, et al.
Publicado: (2020)

BCL-w: apoptotic and non-apoptotic role in health and disease
por: Hartman, Mariusz L., et al.
Publicado: (2020)

BCL-G: 20 years of research on a non-typical protein from the BCL-2 family
por: Hartman, Mariusz L., et al.
Publicado: (2023)

Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
por: Ahmed, Farzana, et al.
Publicado: (2018)

Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance
por: Düchler, Markus, et al.
Publicado: (2019)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres
por: Czyz, Malgorzata, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q4jhg51ta4edbp7m92jj3deu3u